Dolby Laboratories announced its first quarter fiscal 2026 financial results, with total revenue reaching $347 million, a decrease from $357 million in the first quarter of fiscal 2025. GAAP net income was $53 million, or $0.55 per diluted share, down from $68 million, or $0.70 per diluted share in the prior year. Non-GAAP net income was $103 million, or $1.06 per diluted share, compared to $111 million, or $1.14 per diluted share in the first quarter of fiscal 2025.
Total revenue for Q1 fiscal 2026 was $347 million, a decrease from $357 million in Q1 fiscal 2025.
GAAP net income for the quarter was $53 million ($0.55 per diluted share), down from $68 million ($0.70 per diluted share) in the prior year.
Non-GAAP net income was $103 million ($1.06 per diluted share), compared to $111 million ($1.14 per diluted share) in Q1 fiscal 2025.
Dolby repurchased approximately one million shares of its common stock for $70 million, with $207 million of stock repurchase authorization remaining.
Dolby Laboratories provided estimates for the second quarter and full year of fiscal 2026, anticipating total revenue between $375 million and $405 million for Q2, and $1.4 billion to $1.45 billion for the full year. Diluted EPS is projected to be $0.94 to $1.09 (GAAP) and $1.29 to $1.44 (non-GAAP) for Q2, and $2.71 to $2.86 (GAAP) and $4.30 to $4.45 (non-GAAP) for the full year.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance